RecruitingPhase 2NCT06019130

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

Studying Nasopharyngeal carcinoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: German Society for Pediatric Oncology and Hematology GPOH gGmbH
Principal Investigator: Udo Kontny, MD
Uniklinik RWTH Aachen
Intervention: Nivolumab(drug)
Enrollment: 57 target
Eligibility: 3 years · All sexes
Timeline: 2023 – 2028

Study locations (30)

Uniklinik RWTH Aachen, Department of Internal Medicine, Aachen, Germany
Uniklinik RWTH Aachen, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation, Aachen, Germany
Department of Pediatric Oncology and Hematology, Charité University Medicine Berlin, Berlin, Germany
Evangelisches Klinikum Bethel, Children's Hospital, Bielefeld, Germany
Department of Pediatric Hematology and Oncology, University Hospital, Bonn, Germany
Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany
Children's Hospital, Carl-Thiem Klinikum Cottbus, Cottbus, Germany
Clinic for Children and Adolescent Medicine, Klinikum Dortmund, Dortmund, Germany
Department of Internal Medicine, Klinikum Dortmund, Dortmund, Germany
Department of Pediatrics, University Hospital, Technische Universität Dresden, Dresden, Germany
Department fo Radiotherapy, University Hospital, Erlangen, Germany
Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany
Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
Department of Pediatrics, University Hospital, Frankfurt, Germany
+15 more locations on ClinicalTrials.gov

Collaborators

Deutsche Krebshilfe e.V., Bonn (Germany)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06019130 on ClinicalTrials.gov

Other trials for Nasopharyngeal carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Nasopharyngeal carcinoma →

← Back to all trials